World Journal of Laparoscopic Surgery

Register      Login

VOLUME 1 , ISSUE 2 ( May-August, 2008 ) > List of Articles

RESEARCH ARTICLE

Role of Mechanical Dilatation of Cervix in Hysteroscopy

Monique Directo Javier

Citation Information : Javier MD. Role of Mechanical Dilatation of Cervix in Hysteroscopy. World J Lap Surg 2008; 1 (2):20-22.

DOI: 10.5005/jp-journals-10007-1053

Published Online: 01-08-2008

Copyright Statement:  Copyright © 2008; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background

Hysteroscopy with sample of the tissue is the gold standard in the diagnosing of abnormal uterine bleeding. Operative hysteroscopy can then be performed as a therapeutic procedure in patients presenting with intrauterine abnormalities. Cervical dilatation poses a great challenge particularly in nulligravid, post-menopausal women and women with cervical stenosis. Difficulties encountered in dilating the cervix poses threat to complications such as cervical tears, creation of false track, hemorrhage and uterine perforation.

Objective

The aim of this study is to review the role of mechanical dilatation in hysteroscopy using oral and vaginal misoprostol and laminaria.

Methods

This study involves a retrospective analytical review and compares the role of oral and vaginal misoprostol and laminaria application in achieving cervical ripening before hysteroscopy. Its effects in cervical dilatation as well as the dosing, advantages and sideeffects were also reviewed. There were twenty articles included in this study as extracted from electronic databases Cochrane Library, Medscape, Highwire Press and Google. Most of the articles assessed the cervical diameter by the largest number of Hegar dilators that could be inserted into the cervix without resistance. Subjective assessments of adverse effects and complications were recorded.

Conclusion

Methods of cervical priming before hysteroscopy lessens the need of further cervical dilation pre-operatively, lessens the complications associated with the entry of the hysteroscope into the cervical os and offered acceptable side effects.


PDF Share
  1. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA. 202;288:161-62.
  2. ACOG Technology assessment in obstetrics and gynecology, number 4, August, 2005: hysteroscopy. Obstet Gynecol. 2005;106:439-42.
  3. Stovall D Hysteroscopy Version 14.3. Uptodate (cited February 15, 2007).
  4. Complications in hysteroscopy: prevention, treatment, and legal risk. Curr Opin Obstet Gynecol 2002;14:409-15.
  5. Prevention of uterine perforation during curettage abortion. JAMA 1984;251:2108-11.
  6. Measures to prevent cervical injury during suction curettage abortion. Lancet 1983;1:1182-84.
  7. Complications of osmotic dilators. Obstet Gynecol Surv 2004;59:528-36.
  8. Misoprostol for women's health. Obstet Bynecol 2002;99:316-32.
  9. A prospective, randomized, controlled trial comparing vaginal misoprostol and osmotic dilator in achieving cervical ripening before operative hysteroscopy. Gynecological Surgery 2006;3:186-89.
  10. A comparison of vaginal and oral routes in misoprostol administration for cervical priming before hysteroscopy: a prospective randomized double-blind study. Jinekoloji Ve Obstetrik Dergisi 2004;18:145-49.
  11. A randomized placebocontrolled trial of vaginal misoprostol for cervical priming before hysteroscopy in postmenopausal women. BJOG 2002;109;561-65.
  12. The use of oral misoprostol as a cervical ripening agent in operative hysteroscopy: a double blind, placebo controlled trial. Am J Obstet Gynecol 2002;186:876-79.
  13. A randomized controlled trial of vaginal misoprostol for cervical priming before hysteroscopy. Obstet Gynecol 1999;93:427-30.
  14. Oral misoprostol for cervical priming in non-pregnant women. Hum Reprod 1997;12:2373-75.
  15. Herabutya Y. Vaginal misoprostol for cervical priming before operative hysteroscopy, a randomized controlled trial. Obstet Gynecol 2000;96:890-94.
  16. Vaginal misoprostol for cervical ripening before operative hysteroscopy in premenopausal women: a double-blind, placebo controlled trial with three dose regimens. Human Reprod 2004;19:1618-21.
  17. Cervical priming prior to operative hysteroscopy: a randomized comparison of laminaria versus misoprostol. Hum Reprod 2004;19:2391-94.
  18. Vaginal misoprostol for cervical dilatation before operative office hysteroscopy. Gynael Endoscopy 1997;6:47-49.
  19. The use of misoprostol prior to hysteroscopy in post-menopausal women. Hum Reprod 2001;16:1486-88.
  20. Oral misoprostol before office endometrial biopsy. Obstet Gynecol 2002;99:439-44.
  21. The use of oral misoprostol as a cervical ripening agent in operative hysteroscopy; a double blind placebo controlled trial. Am J Obstet Gynecol 2002;186;876-79.
  22. A randomized trial of sublingual misoprostol for cervical priming before hysteroscopy. J Am Assoc Gynecol Laparosc 2003;10:390-91.
  23. Vaginal misoprostol for cervical priming before dilatation and curettage in post-menopausal women; a randomised controlled trial. J Obstet Gynaecol Res 2004;30:221-25.
  24. Vaginal misoprostol for cervical priming before hysteroscopy in perimenopausal and postmenopausal women. Int J Gynaecol Obstet 2005;91:141-45.
  25. Misoprostol for cervical ripening in nonpregnant women: a randomized double-blind controlled trial of oral versus vaginal regimens. Hum Reprod 2006;21:2167-70.
  26. Comparison of self-administered vaginal misoprostol versus placebo for cervical priming prior to operative hysteroscopy using a sequential trial design. BJOG 2007;114:769.
  27. Use of misoprostol before hysteroscopy: a systematic review. J Obstet Gynaecol Can 2006;28:373-79.
  28. Cervical priming prior to operative hysteroscopy: a randomized comparison of laminaria versus misoprostol. Hum Reprod 2004; 19: 2391-94.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.